TR-4

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTR-4
Drug Alias NameTR-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor antagonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsHeart FailureAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrio Medicines Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTrio Medicines Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A